IL10 and COVID-19: We expect focused clinical analysis, above all the identification of the location and cellular source of IL-10 production, combined with the use of recombinant viruses in animal models that replicate the clinical phenotype of COVID-19 to reveal the underlying viral trigger and IL-10 dependent pathways.